| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Bivalirudin during primary PCI in acute myocardial infarction.
|
N Engl J Med
|
2008
|
5.86
|
|
2
|
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.
|
Lancet
|
2011
|
3.00
|
|
3
|
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.
|
Lancet
|
2009
|
2.82
|
|
4
|
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study.
|
Circ Cardiovasc Interv
|
2015
|
2.67
|
|
5
|
Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
|
J Am Coll Cardiol
|
2011
|
2.49
|
|
6
|
Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
|
Circulation
|
2011
|
2.18
|
|
7
|
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
|
N Engl J Med
|
2009
|
1.72
|
|
8
|
Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
|
J Am Coll Cardiol
|
2011
|
1.72
|
|
9
|
Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.
|
J Am Coll Cardiol
|
2015
|
1.61
|
|
10
|
Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
|
J Am Coll Cardiol
|
2014
|
1.51
|
|
11
|
Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial.
|
J Am Coll Cardiol
|
2012
|
1.51
|
|
12
|
Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes.
|
JACC Cardiovasc Interv
|
2012
|
1.50
|
|
13
|
Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial.
|
JACC Cardiovasc Interv
|
2010
|
1.46
|
|
14
|
Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial.
|
EuroIntervention
|
2013
|
1.41
|
|
15
|
Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.
|
Catheter Cardiovasc Interv
|
2014
|
1.40
|
|
16
|
Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial.
|
Circulation
|
2011
|
1.31
|
|
17
|
Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
|
J Am Coll Cardiol
|
2010
|
1.16
|
|
18
|
Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
|
J Am Coll Cardiol
|
2009
|
1.12
|
|
19
|
Paclitaxel-eluting stents compared with bare metal stents in diabetic patients with acute myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
|
Circ Cardiovasc Interv
|
2011
|
1.11
|
|
20
|
Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy.
|
Circ Cardiovasc Interv
|
2011
|
1.04
|
|
21
|
Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
|
Circulation
|
2010
|
0.96
|
|
22
|
Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial.
|
Int J Cardiol
|
2012
|
0.95
|
|
23
|
The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
|
JACC Cardiovasc Interv
|
2011
|
0.89
|
|
24
|
Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial.
|
Circulation
|
2011
|
0.88
|
|
25
|
Comparison of outcomes in patients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).
|
Am J Cardiol
|
2014
|
0.87
|
|
26
|
The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale.
|
Am Heart J
|
2008
|
0.87
|
|
27
|
Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).
|
J Am Coll Cardiol
|
2013
|
0.86
|
|
28
|
Long-term follow-up of attenuated plaques in patients with acute myocardial infarction: an intravascular ultrasound substudy of the HORIZONS-AMI trial.
|
Circ Cardiovasc Interv
|
2012
|
0.84
|
|
29
|
Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial.
|
JACC Cardiovasc Interv
|
2011
|
0.84
|
|
30
|
Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials.
|
Circ Cardiovasc Interv
|
2015
|
0.83
|
|
31
|
Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial.
|
EuroIntervention
|
2013
|
0.82
|
|
32
|
B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
|
Circ Cardiovasc Interv
|
2012
|
0.82
|
|
33
|
Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy.
|
Circulation
|
2009
|
0.81
|
|
34
|
Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trial.
|
JACC Cardiovasc Imaging
|
2013
|
0.81
|
|
35
|
Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.
|
EuroIntervention
|
2013
|
0.81
|
|
36
|
Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.
|
Circ Cardiovasc Interv
|
2014
|
0.80
|
|
37
|
Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial.
|
Am Heart J
|
2013
|
0.80
|
|
38
|
Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Patient-Level Analysis of 2 Randomized Trials.
|
Circ Cardiovasc Interv
|
2016
|
0.79
|
|
39
|
Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial.
|
EuroIntervention
|
2013
|
0.78
|
|
40
|
Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
|
Am Heart J
|
2011
|
0.77
|
|
41
|
Leukocyte count is a modulating factor for the mortality benefit of bivalirudin in ST-segment-elevation acute myocardial infarction: the HORIZONS-AMI trial.
|
Circ Cardiovasc Interv
|
2013
|
0.77
|
|
42
|
Impact of multiple complex plaques on short- and long-term clinical outcomes in patients presenting with ST-segment elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Trial).
|
Am J Cardiol
|
2014
|
0.75
|
|
43
|
Impact of advanced age on the safety and effectiveness of paclitaxel-eluting stent implantation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: The HORIZONS-AMI trial.
|
Catheter Cardiovasc Interv
|
2013
|
0.75
|
|
44
|
Utility of post-procedural anticoagulation after primary PCI for STEMI: insights from a pooled analysis of the HORIZONS-AMI and EUROMAX trials.
|
Eur Heart J Acute Cardiovasc Care
|
2016
|
0.75
|
|
45
|
Cerebrovascular events after a primary percutaneous coronary intervention strategy for acute ST-segment-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial.
|
Circ Cardiovasc Interv
|
2015
|
0.75
|
|
46
|
Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
|
Circ Cardiovasc Interv
|
2013
|
0.75
|